ANDA 63161, held by Hospira. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 63161 (Tobramycin Sulfate), held by Hospira, was first approved by FDA on May 29, 1991, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 29, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin SulfateEQ 40MG BASE/ML ยท injectable;injection | Tobramycin Sulfate | Discontinued |
| Feb 16, 1999 | Supplement 4Manufacturing | Approved | None posted |
| Dec 10, 1993 | Supplement 2Labeling | Approved | None posted |
| May 20, 1993 | Supplement 1Manufacturing | Approved | None posted |
| May 29, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters